Patents by Inventor Holger Moch

Holger Moch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160054037
    Abstract: A refrigeration device has an evaporator for evaporating a refrigerant. The evaporator includes an inlet pipe for the admission of the refrigerant, in which inlet pipe there is formed a pipe region, which has a first flow cross section, and a constriction region, which has a second flow cross section that is smaller than the first flow cross section. A method is also described for producing such an evaporator.
    Type: Application
    Filed: April 3, 2014
    Publication date: February 25, 2016
    Inventors: REINHARD MEHNER, DANIEL MICKO, HOLGER MOCH, BERND SCHLOEGEL, ANDREAS VOGL
  • Patent number: 8519106
    Abstract: Provided are novel human tumor-specific antibodies as well as fragments, derivatives and variants thereof that recognize tumor-associated antigen NY-ESO-1. In addition, pharmaceutical compositions comprising such antibodies and mimics thereof in the treatment of tumors are described.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: August 27, 2013
    Assignee: University of Zurich
    Inventors: Christoph Esslinger, Sandra Künzle, Irene Abela, Alfred Zippelius, Dirk Jäger, Alexander Knuth, Roger Nitsch, Holger Moch, Norbert Göbels
  • Publication number: 20130157887
    Abstract: The present invention describes the use of discrete states and signatures for classifying samples.
    Type: Application
    Filed: May 12, 2011
    Publication date: June 20, 2013
    Inventors: Manfred Beleut, Peter Schraml, Holger Moch, Michael Baudis, Philip Zimmermann, Wilhelm Gruissem, Karsten Henco
  • Publication number: 20110123447
    Abstract: Provided are novel tumor-specific binding molecules, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize tumor-associated antigens and that are obtained from a tumor patient who shows at least partial clinical response or is symptom-free. In addition, pharmaceutical compositions comprising such binding molecules, antibodies and mimics thereof and methods of screening for novel binding molecules, which may or may not be antibodies as well as targets in the treatment of tumors are described.
    Type: Application
    Filed: March 13, 2008
    Publication date: May 26, 2011
    Applicant: UNIVERSITY OF ZURICH
    Inventors: Christoph Esslinger, Sandra Kuenzle, Irene Abela, Roger Nitsch, Holger Moch, Norbert Goebels, Dirk Jaeger, Alfred Zippelius, Alexander Knuth
  • Publication number: 20100330075
    Abstract: Provided are novel human tumor-specific antibodies as well as fragments, derivatives and variants thereof that recognize tumor-associated antigen NY-ESO-1. In addition, pharmaceutical compositions comprising such antibodies and mimics thereof in the treatment of tumors are described.
    Type: Application
    Filed: March 13, 2008
    Publication date: December 30, 2010
    Inventors: Christoph Esslinger, Sandra Kuenzle, Irene Abela, Alfred Zippelius, Dirk Jaeger, Alexander Knuth, Roger Nitsch, Holger Moch, Norbert Goebels